{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:23:00Z","timestamp":1792095780983,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:00:00Z","timestamp":1794355200000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114349","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:03:27Z","timestamp":1761930207000},"page":"114349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P2","title":["Hydrogel formulations for sustained-release of broadly neutralizing antibodies"],"prefix":"10.1016","volume":"388","author":[{"given":"Carolyn K.","family":"Jons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Kasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ollivier","family":"Hyrien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samya","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Meany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I.","family":"d'Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Eckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslee T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Doulames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Eun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Saouaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114349_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/v16060911","article-title":"The use of broadly neutralizing antibodies (bNAbs) in HIV-1 treatment and prevention","volume":"16","author":"Thavarajah","year":"2024","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.jconrel.2025.114349_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nri.2017.148","article-title":"Passive immunotherapy of viral infections: \u2018super-antibodies\u2019 enter the fray","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/infdis\/jiaa377","article-title":"Clinical trials of broadly neutralizing monoclonal antibodies for human immunodeficiency virus prevention: a review","volume":"223","author":"Mahomed","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114349_bb0020","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0025","series-title":"Mucosal Immunology","first-page":"1403","volume":"vol. 2","author":"Marcotte","year":"2015"},{"key":"10.1016\/j.jconrel.2025.114349_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/COH.0000000000000742","article-title":"Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection","volume":"17","author":"Awan","year":"2022","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jconrel.2025.114349_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00405-19","article-title":"Human monoclonal antibodies potently neutralize Zika virus and select for escape mutations on the lateral ridge of the envelope protein","volume":"93","author":"Bailey","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114349_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2021.104807","article-title":"Anti-malarial humoral immunity: the long and short of it","volume":"23","author":"Rogers","year":"2021","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2025.114349_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiae511","article-title":"Vaccines for Global Health: progress and challenges","volume":"232","author":"Knisely","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.114349_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/22221751.2020.1713707","article-title":"Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities","volume":"9","author":"Liu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jconrel.2025.114349_bb0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41591-019-0412-8","article-title":"Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic","volume":"25","author":"Caskey","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114349_bb0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/psp4.12224","article-title":"Pharmacokinetics of monoclonal antibodies","volume":"6","author":"Ryman","year":"2017","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114349_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105788","article-title":"Next-generation bNAbs for HIV-1 cure strategies","volume":"222","author":"Schriek","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jconrel.2025.114349_bb0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2019.07.007","article-title":"The potential of engineered antibodies for HIV-1 therapy and cure","volume":"38","author":"Grobben","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40259-021-00471-0","article-title":"Recent achievements and challenges in prolonging the serum half-lives of therapeutic IgG antibodies through fc engineering","volume":"35","author":"Ko","year":"2021","journal-title":"Biodrugs"},{"key":"10.1016\/j.jconrel.2025.114349_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102402","article-title":"Fc-engineered therapeutic antibodies: recent advances and future directions","volume":"15","author":"Abdeldaim","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114349_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16050594","article-title":"Impact of LS mutation on pharmacokinetics of preventive HIV broadly neutralizing monoclonal antibodies: a cross-protocol analysis of 16 clinical trials in people without HIV","volume":"16","author":"Mayer","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114349_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2018.08.001","article-title":"Subcutaneous delivery of monoclonal antibodies: how do we get there?","volume":"286","author":"Viola","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114349_bb0105","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41591-022-01815-1","article-title":"Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial","volume":"28","author":"Julg","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114349_bb0110","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/s41591-021-01509-0","article-title":"Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114349_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01860","article-title":"Engineering of fc fragments with optimized physicochemical properties implying improvement of clinical potentials for Fc-based therapeutics","volume":"8","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12100999","article-title":"Injectables and depots to prolong drug action of proteins and peptides","volume":"12","author":"Ibeanu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114349_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejpb.2014.08.001","article-title":"Controlled release of therapeutic antibody formats","volume":"88","author":"Schweizer","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114349_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/biolre\/ioaa096","article-title":"Engineering monoclonal antibody-based contraception and multipurpose prevention technologies","volume":"103","author":"Anderson","year":"2020","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jconrel.2025.114349_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404660","article-title":"Reinforced polymer-nanoparticle hydrogels for subcutaneous and sustained delivery of Trastuzumab","volume":"14","author":"Bovone","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114349_bb0140","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mabi.201500226","article-title":"Microfluidic production of alginate hydrogel particles for antibody encapsulation and release","volume":"15","author":"Mazutis","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2017.08.006","article-title":"Injectable hydrogels for sustained release of therapeutic agents","volume":"267","author":"Thambi","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114349_bb0150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jconrel.2013.10.010","article-title":"Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation","volume":"172","author":"Schweizer","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114349_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1021\/bm301352x","article-title":"Protein-Polyanion interactions for the controlled release of monoclonal antibodies","volume":"14","author":"Schweizer","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.114349_bb0160","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.xphs.2018.11.038","article-title":"Alginate-based delivery Systems for Bevacizumab Local Therapy: structural features and release properties","volume":"108","author":"Ferreira","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2012.03.014","article-title":"Two-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies","volume":"160","author":"Koutsopoulos","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114349_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejpb.2014.12.029","article-title":"Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics","volume":"95","author":"Lovett","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114349_bb0175","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/mabi.201500245","article-title":"Long-term controlled protein release from poly(ethylene glycol) hydrogels by modulating mesh size and degradation","volume":"15","author":"Tong","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.xphs.2022.11.022","article-title":"Pharmacokinetic evaluation of thermosensitive sustained release formulations developed for subcutaneous delivery of protein therapeutics","volume":"112","author":"Rajadhyaksha","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0185","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1021\/acs.chemrev.0c01177","article-title":"Translational applications of hydrogels","volume":"121","author":"Correa","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.114349_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nmat4474","article-title":"Supramolecular Biomaterials","volume":"15","author":"Webber","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.114349_bb0195","article-title":"A quantitative description for designing the extrudability of shear-thinning physical hydrogels","volume":"21","author":"Hernandez","year":"2021","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/C7BM00780A","article-title":"Supramolecular polymeric biomaterials","volume":"6","author":"Mann","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202203402","article-title":"Yield-stress and creep control depot formation and persistence of injectable hydrogels following subcutaneous administration","volume":"32","author":"Jons","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114349_bb0210","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1039\/D4BM01315H","article-title":"A thiol-ene click-based strategy to customize injectable polymer-nanoparticle hydrogel properties for therapeutic delivery","volume":"13","author":"Bailey","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801147","article-title":"A biocompatible therapeutic catheter-deliverable hydrogel for in situ tissue engineering","volume":"8","author":"Steele","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114349_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404498","article-title":"Sustained vaccine exposure elicits more rapid, consistent, and broad humoral immune responses to multivalent influenza vaccines","volume":"12","author":"Saouaf","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0225","article-title":"Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management","volume":"4","author":"d\u2019Aquino","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2025.114349_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301495","article-title":"Broad and durable humoral responses following single hydrogel immunization of SARS-CoV-2 subunit vaccine","volume":"12","author":"Ou","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114349_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn8264","article-title":"Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumors","volume":"8","author":"Grosskopf","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114349_bb0240","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acscentsci.0c00732","article-title":"Injectable hydrogels for sustained Codelivery of subunit vaccines enhance humoral immunity","volume":"6","author":"Roth","year":"2020","journal-title":"Acs Central Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0245","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1039\/D2BM00819J","article-title":"Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot","volume":"11","author":"Kasse","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0250","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr2631","article-title":"Generation of an inflammatory niche in a hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines","volume":"11","author":"Meany","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114349_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7295","article-title":"Self-assembled hydrogels utilizing polymer-nanoparticle interactions","volume":"6","author":"Appel","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114349_bb0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1039\/C9ME00120D","article-title":"Structural considerations for physical hydrogels based on polymer-nanoparticle interactions","volume":"5","author":"Yu","year":"2020","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.jconrel.2025.114349_bb0265","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/pol.20210652","article-title":"Gelation and yielding behavior of polymer-nanoparticle hydrogels","volume":"59","author":"Grosskopf","year":"2021","journal-title":"J. Polym. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0270","article-title":"Injectable polymer-nanoparticle hydrogel for the sustained intravitreal delivery of Bimatoprost","volume":"6","author":"Meany","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2025.114349_bb0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release II. Fickian and anomalous release from swellable devices","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114349_bb0280","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0161-5890(87)90024-1","article-title":"Thermal-properties of human-igg","volume":"24","author":"Rosenqvist","year":"1987","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0285","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1021\/acsbiomaterials.0c01306","article-title":"Self-assembled, dilution-responsive hydrogels for enhanced thermal stability of insulin biopharmaceuticals","volume":"7","author":"Meis","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2025.114349_bb0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41551-019-0442-z","article-title":"Use of a supramolecular polymeric hydrogel as an effective post-operative pericardial adhesion barrier","volume":"3","author":"Stapleton","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114349_bb0295","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02011-17","article-title":"eCD4-Ig variants that more potently neutralize HIV-1","volume":"92","author":"Fetzer","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0300","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature14264","article-title":"AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges","volume":"519","author":"Gardner","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114349_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003342","article-title":"Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding Glycans","volume":"9","author":"Julien","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2025.114349_bb0310","series-title":"Pharmacokinetics-Based Design of Subcutaneous Controlled Release Systems for Biologics","author":"Grosskopf","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114349_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103677","article-title":"Injectable nanoparticle-based hydrogels enable the safe and effective deployment of Immunostimulatory CD40 agonist antibodies","volume":"9","author":"Correa","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114349_bb0325","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cpt.3150","article-title":"Subcutaneous administration of monoclonal antibodies: pharmacology, delivery, immunogenicity, and learnings from applications to clinical development","volume":"115","author":"Davis","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2025.114349_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030636","article-title":"Biomaterials: foreign bodies or tuners for the immune response?","volume":"20","author":"Mariani","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114349_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202400077","article-title":"A cGAMP-containing hydrogel for prolonged SARS-CoV-2 receptor-binding domain subunit vaccine exposure induces a broad and potent humoral response","volume":"5","author":"B\u00f6hnert","year":"2025","journal-title":"Adv. Nanobiomed. Res."},{"key":"10.1016\/j.jconrel.2025.114349_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02758-0","article-title":"Tailoring biomaterials for vaccine delivery","volume":"22","author":"Zhuo","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0345","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acsbiomaterials.2c00026","article-title":"Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems","volume":"8","author":"Madamsetty","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2025.114349_bb0350","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cytogfr.2021.01.001","article-title":"Granulocyte macrophage colony-stimulating factor has come of age: from a vaccine adjuvant to antiviral immunotherapy","volume":"59","author":"Petrina","year":"2021","journal-title":"Cytokine Growth F R"},{"key":"10.1016\/j.jconrel.2025.114349_bb0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3934\/biophy.2025006","article-title":"Subcutaneous sustained-release drug delivery system for antibodies and proteins","volume":"12","author":"Yoshida","year":"2025","journal-title":"Aims Biophys."},{"key":"10.1016\/j.jconrel.2025.114349_bb0360","doi-asserted-by":"crossref","first-page":"E667","DOI":"10.1016\/S2352-3018(19)30181-X","article-title":"Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial","volume":"6","author":"Gaudinski","year":"2019","journal-title":"Lancet Hiv"},{"key":"10.1016\/j.jconrel.2025.114349_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109809","article-title":"Broadly neutralizing antibodies targeting HIV: Progress and challenges","volume":"257","author":"Paneerselvam","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0370","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-153355","article-title":"A phase 1 dose escalation study of Igm-2323, a novel anti-CD20 x anti-CD3 IgM T cell engager (TCE) in patients with advanced B-cell malignancies","volume":"138","author":"Budde","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.114349_bb0375","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1535-7163.MCT-20-1132","article-title":"Multimeric anti-DR5 IgM agonist antibody IGM-8444 is a potent inducer of Cancer cell apoptosis and synergizes with chemotherapy and BCL-2 inhibitor ABT-199","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2025.114349_bb0380","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14712598.2024.2436094","article-title":"Strategies for extending the half-life of biotherapeutics: successes and complications","volume":"25","author":"Binder","year":"2025","journal-title":"Expert Opin. Biol. Th."},{"key":"10.1016\/j.jconrel.2025.114349_bb0385","first-page":"1529","article-title":"Modified therapeutic antibodies: improving efficacy","volume":"7","author":"Dai","year":"2021","journal-title":"Engineering-Prc"},{"key":"10.1016\/j.jconrel.2025.114349_bb0390","doi-asserted-by":"crossref","DOI":"10.1039\/D0MA00760A","article-title":"Review of the current state of protein aggregation inhibition from a materials chemistry perspective: special focus on polymeric materials","volume":"2","author":"Rajan","year":"2021","journal-title":"Mater. Adv."},{"key":"10.1016\/j.jconrel.2025.114349_bb0395","article-title":"Small-angle neutron scattering reveals structural hierarchy of polymer-nanoparticle hydrogels","author":"Eckman","year":"2025","journal-title":"ChemRxiv"},{"key":"10.1016\/j.jconrel.2025.114349_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10147","article-title":"Injectable supramolecular polymer-nanoparticle hydrogels enhance human mesenchymal stem cell delivery","volume":"5","author":"Grosskopf","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114349_bb0405","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/jbm.a.37203","article-title":"Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunity","volume":"109","author":"Saouaf","year":"2021","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2025.114349_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.709994","article-title":"Validation of a triplex pharmacokinetic assay for simultaneous quantitation of HIV-1 broadly neutralizing antibodies PGT121, PGDM1400, and VRC07-523-LS","volume":"12","author":"Wesley","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0415","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","article-title":"Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1","volume":"409","author":"Sarzotti-Kelsoe","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2025.114349_bb0420","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-62703-050-2_17","article-title":"Compartmental modeling in the analysis of biological systems","volume":"929","author":"Bassingthwaighte","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114349_bb0425","series-title":"Simulations Plus","author":"Monolix 2024R1","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114349_bb0430","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.addr.2006.09.007","article-title":"Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems","volume":"58","author":"Arifin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114349_bb0435","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(24)00247-9","volume":"12","author":"Edupuganti","year":"2025","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2025.114349_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/antib9040053","article-title":"Structure, function, and therapeutic use of IgM antibodies","volume":"9","author":"Keyt","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.jconrel.2025.114349_bb0445","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1172\/JCI104987","article-title":"Metabolism of human gamma macroglobulins","volume":"43","author":"Barth","year":"1964","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:52:29Z","timestamp":1780822349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":89,"alternative-id":["S0168365925009630"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114349","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogel formulations for sustained-release of broadly neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114349"}}